Brian Mann All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company’s improper marketing of opioids. The deal was filed with a federal bankruptcy court by Purdue Pharma officials in March after negotiations with state attorneys general…